BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 24222151)

  • 1. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim CW; Yu CS; Yang SS; Kim KH; Yoon YS; Yoon SN; Lim SB; Kim JC
    Ann Surg Oncol; 2011 Nov; 18(12):3271-7. PubMed ID: 21537868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Saigusa S; Tanaka K; Mohri Y; Kusunoki M
    Int Surg; 2015 Feb; 100(2):199-207. PubMed ID: 25692418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer.
    Huang CS; Lin JK; Wang LW; Liang WY; Lin CC; Lan YT; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC; Chang SC
    Am J Surg; 2014 Jul; 208(1):99-105. PubMed ID: 24524862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer.
    Koca D; Binicier C; Oztop I; Yavuzsen T; Ellidokuz H; Yilmaz U
    J BUON; 2012; 17(2):291-8. PubMed ID: 22740208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
    Ide S; Toiyama Y; Okugawa Y; Oki S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Kobayashi M; Ohi M; Araki T; Kusunoki M
    Anticancer Res; 2017 Oct; 37(10):5797-5804. PubMed ID: 28982904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.
    Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC
    Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence.
    Song S; Hong JC; McDonnell SE; Koong AC; Minsky BD; Chang DT; Liauw SL
    Ann Surg Oncol; 2012 Aug; 19(8):2471-6. PubMed ID: 22327251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
    Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
    Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery.
    Cienfuegos JA; Rotellar F; Baixauli J; Beorlegui C; Sola JJ; Arbea L; Pastor C; Arredondo J; Hernández-Lizoáin JL
    Ann Surg Oncol; 2015 Mar; 22(3):916-23. PubMed ID: 25190129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy rather than neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer with high tumor burden.
    Koca D; Oztop J; Yilmaz U
    Hepatogastroenterology; 2012 Oct; 59(119):2151-4. PubMed ID: 22440247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer.
    Li A; He K; Guo D; Liu C; Wang D; Mu X; Yu J
    Future Oncol; 2019 Oct; 15(28):3233-3242. PubMed ID: 31373223
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
    Yang KL; Yang SH; Liang WY; Kuo YJ; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Chu LS; Wang LW
    Radiat Oncol; 2013 Mar; 8():43. PubMed ID: 23452434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
    Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
    Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.
    Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC
    Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.